InflaRx (IFRX) Cash from Operations (2016 - 2026)

InflaRx's (IFRX) quarterly Cash from Operations came in at 8654555.75 in Q1 2026, up 41.3% year-on-year from 6125095.85 in Q1 2025, and down 58.0% quarter-over-quarter from 5477523.16 in Q4 2025.

InflaRx (IFRX) Cash from Operations (2016 - 2026) Analysis & Trends

InflaRx has disclosed Cash from Operations across 11 years of filings, most recently posting 8654555.75 for Q1 2026.

  • Cash from Operations for Q1 2026 came in at 8654555.75, up 41.3% year-over-year; the trailing twelve-month figure through Mar 2026 was 33250090.41 (up 34.97% YoY), and the FY2025 annual result was 41107414.48, up 20.78% from the prior year.
  • Cash from Operations came in at 8654555.75 for Q1 2026 at InflaRx, down from 5477523.16 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 3192978.95 in Q3 2022 to a low of 16152422.19 in Q1 2024.
  • The 5-year median for Cash from Operations is 11287469.73 (2023), against an average of 10452114.66.
  • Across the five-year window, Cash from Operations jumped 72.82% in 2022 and sank 119.84% in 2023, its largest moves.
  • InflaRx's Cash from Operations stood at 5322589.69 in 2022, then sank by 119.84% to 11701228.47 in 2023, then fell by 8.63% to 12710728.57 in 2024, then soared by 56.91% to 5477523.16 in 2025, then tumbled by 58.0% to 8654555.75 in 2026.
  • The last three Cash from Operations figures came in at 8654555.75 (Q1 2026), 5477523.16 (Q4 2025), and 10568212.43 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -1.67 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -12.20 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -2.49 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.43 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 -8.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.65 Mn
Mar 31, 2026 -8.65 Mn
Dec 31, 2025 -5.48 Mn
Dec 31, 2025 -5.48 Mn
Sep 30, 2025 -10.57 Mn
Sep 30, 2025 -10.57 Mn
Jun 30, 2025 -8.55 Mn
Jun 30, 2025 -8.55 Mn
Mar 31, 2025 -14.74 Mn
Mar 31, 2025 -14.74 Mn
Dec 31, 2024 -12.71 Mn
Dec 31, 2024 -12.71 Mn
Sep 30, 2024 -10.61 Mn
Sep 30, 2024 -10.61 Mn
Jun 30, 2024 -13.07 Mn
Jun 30, 2024 -13.07 Mn
Mar 31, 2024 -16.15 Mn
Mar 31, 2024 -16.15 Mn
Dec 31, 2023 -11.70 Mn
Dec 31, 2023 -11.70 Mn